Fundraising FoxVitanova Biomedical
Kerrville, US · Texas corporation
Find your way into Vitanova Biomedical
Sign up to see every warm intro you have to Vitanova Biomedical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Vitanova Biomedical team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Vitanova Biomedical develops cancer treatments based on a proprietary light-activated intracellular acidosis (LAIA) therapy that uses upconverting nanoparticles and deep-penetrating light to induce cancer cell death. The company operates in the biomedical and oncology therapeutics space.
Founders & leadership
MG
Matthew GdovinFounder & Chief Science Officer
Reported raises · per SEC filings
Form D private placements$745K disclosed across 2 of 3 rounds · 2018–2026
▶$8MofferedMay 2026 · BiotechnologyRule 506(b)
▶$8MofferedMay 2026 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Matthew J GdovinExecutive Officer
- Offering amount
- $8M
- Minimum investment
- $25K
- Proceeds to insiders
- $110K
- Incorporated
- Corporation, Texas
- Federal exemptions
- 06b, 3C, 3C.1
▶$325KraisedJun 2021 · 5 investors · BiotechnologyRule 506(b)
▶$325KraisedJun 2021 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- MATTHEW GDOVINExecutive Officer, Director
- GREG ESPENHOVERExecutive Officer, Director
- THOMAS C/O VITANOVA BIOMEDICAL, INC. ROBERTSExecutive Officer, Director
- Offering amount
- $6.5M
- Amount sold
- $325K
- Minimum investment
- $25K
- Sales commissions
- $150K
- Proceeds to insiders
- $600K
- Placement agents
- THE OCMX
- First sale
- Aug 2019
- Incorporated
- Corporation, Texas
- Federal exemptions
- 06b
▶$420KraisedAug 2019 · 8 investors · BiotechnologyRule 506(b)
▶$420KraisedAug 2019 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- GREG ESPENHOVERExecutive Officer, Director
- THOMAS ROBERTSExecutive Officer, Director
- MATTHEW GDOVINExecutive Officer, Director
- Offering amount
- $420K
- Amount sold
- $420K
- Minimum investment
- $5K
- Proceeds to insiders
- $220K
- First sale
- Feb 2018
- Incorporated
- Corporation, Texas, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 5
BioworldBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Synnovation TherapeuticsA drug discovery company founded by an experienced medicinal chemistry team with expertise in successful pharmaceutical development and clinical advancement.
Minerva BiotechnologiesMinerva Biotechnologies develops cancer and stem cell therapeutics, including cancer immunotherapies aimed at solid tumors and preventing cancer metastasis. The company also works on patient-derived stem cells for regenerative medicine.
Northwest BiotherapeuticsNW Bio develops personalized dendritic cell-based cancer vaccines intended to treat a range of solid tumor cancers as an alternative to chemotherapy. Its clinical-stage products target cancers including glioblastoma, inoperable solid tumors, ovarian cancer, and prostate cancer.
VianovatxVia Nova develops antiviral therapies targeting acute and subacute viral infections, including respiratory, gastrointestinal, and neurological infections. The company focuses on infections with high prevalence and severe illness potential, serving patients with unmet treatment needs across multiple viral categories.
Companies working in the same space as Vitanova Biomedical.
Frequently asked questions
- What does Vitanova Biomedical do?
- Vitanova Biomedical develops cancer treatments based on a proprietary light-activated intracellular acidosis (LAIA) therapy that uses upconverting nanoparticles and deep-penetrating light to induce cancer cell death. The company operates in the biomedical and oncology therapeutics space.
- Who founded Vitanova Biomedical?
- Vitanova Biomedical was founded by Matthew Gdovin.
- How much funding has Vitanova Biomedical raised?
- Vitanova Biomedical has disclosed $745K raised across 2 of its 3 known rounds.
- Where is Vitanova Biomedical headquartered?
- Vitanova Biomedical is headquartered in Kerrville, US.